News FDA Approves Eylea for Macular Edema Following CRVO by Medscape • 2012/09/22 • 0 Comments The FDA decision expands the indication of the angiogenesis inhibitor, which is already approved for neovascular age-related macular degeneration. FDA Approvals Full Story →